Cilnidipine is a calcium channel blocker compound used as an active pharmaceutical ingredient. It is notably approved for use in Japan, China, India, Nepal, and Korea for the management of hypertension.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 132203-70-4
Pranidipine
calcium channel blocker antihypertensive agent
2-(Dimethylamino)ethanethiol hydrochloride
pharmaceutical raw material
올란자핀
active pharmaceutical ingredient
Tulobuterol-d9 Hydrochloride
research compound
6-methyl-2-ethyl-3-hydroxypyridine hydrochloride
active pharmaceutical ingredient
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrosophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Nitrosamine impurity reference standard
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
KJEBULYHNRNJTE-DHZHZOJOSA-N
CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC